View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 17, 2022updated 17 Feb 2022 7:13am

MicroPort CRM secures approval for Alizea pacemakers in Japan

Together with SmartView Connect home monitor, Alizea pacemakers can provide a patient’s clinical status to cardiologists.

MicroPort CRM has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its new range of Alizea pacemakers equipped with Bluetooth technology.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The new implantable pacemakers are paired with the company’s SmartView Connect home monitor, which helps to streamline remote monitoring.

The home monitor system provides cardiologists with detailed patient reports and timely alerts, as well as offering advanced remote monitoring and follow-up.

It can be placed at the patient’s bedside for regular transmission of detailed patient reports regarding the functioning of the pacing system.

The device reduces the burden on the healthcare system and eliminates the need for patients to visit the hospital for routine check-ups.

Together, the Alizea pacemakers and the SmartView Connect home monitor provide cardiologists with timely alerts of a patient’s clinical status.

This helps in providing quicker and more efficient patient care.

MicroPort CRM Sales Japan vice-president Noboru Shimizu said: “Around 64,000 patients are implanted with a pacemaker each year in Japan and, coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel.

“Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”

The latest Alizea pacemakers include AutoMRI, which helps to automatically protect patients when they undergo MRI scans.

A Sleep Apnea Monitoring (SAM) feature is also included in the latest generation of pacemakers. This can help to reveal under-diagnosed diseases with significant cardiac comorbidities, such as atrial fibrillation.

The pacemakers also feature SafeR, a pacing mode that is proven to prevent the first onset of atrial fibrillation by minimising unnecessary ventricular pacing.

Last October, German medical device manufacturer Hemovent was acquired by MicroPort Surgical, a critical care subsidiary of MicroPort Scientific.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network